Antares Pharma
ATRS
#5585
Rank
C$1.32 B
Marketcap
$7.76
Share price
0.00%
Change (1 day)
28.75%
Change (1 year)

P/E ratio for Antares Pharma (ATRS)

P/E ratio at the end of 2020: 11.9

According to Antares Pharma's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.4412. At the end of 2020 the company had a P/E ratio of 11.9.

P/E ratio history for Antares Pharma from 2001 to 2020

PE ratio at the end of each year

Year P/E ratio Change
202011.9-102.55%
2019-465554.93%
2018-71.0292.46%
2017-18.124.23%
2016-14.664.42%
2015-8.86-6.95%
2014-9.52-64.58%
2013-26.9-30.91%
2012-38.9-11.59%
2011-44.080.12%
2010-24.4213.76%
2009-7.79335.08%
2008-1.79-73.9%
2007-6.86-8.57%
2006-7.501.61%
2005-7.3824.82%
2004-5.911093.56%
2003-0.495463.35%
2002-0.3033-85.57%
2001-2.10

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-124-855.50%๐Ÿ‡บ๐Ÿ‡ธ USA
40.9 148.89%๐Ÿ‡บ๐Ÿ‡ธ USA
43.1 161.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.4-163.43%๐Ÿ‡บ๐Ÿ‡ธ USA
14.8-10.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.75-153.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
11.1-32.32%๐Ÿ‡บ๐Ÿ‡ธ USA
147 793.36%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.